At the 2026 Science of Skin Summit, Allergan Aesthetics, an AbbVie company, presented its latest research on aging, regenerative aesthetics, and exosome-based skincare. The company introduced the FACTS Principles, a scientific framework by SkinMedica® to ensure consistent evaluation of exosome skincare products, focusing on formulation, stability, safety, and clinical evidence. This initiative aims to promote transparency and rigorous scientific standards in the emerging field of exosome skincare, which holds promise for skin longevity and biological function. Allergan's R&D leaders also shared insights from over 25 years of research and numerous clinical studies, emphasizing evidence-based innovation in skincare.
Following Allergan Aesthetics' presentation at the 2026 Science of Skin Summit, AbbVie Inc (ABBV) shares show stability on Pluang, priced at USD 261.69 with no change in the last day as of Sep 15, 2026 19:14 WIB. The stock remains close to its 52-week high of USD 265.97, reflecting steady investor interest in AbbVie's health sector innovations.
A $250,000 retirement rollover invested in five dividend-paying stocks—Verizon, AbbVie, Realty Income, Altria, and Exxon Mobil—shows varied yields and risks. Realty Income stands out with a 5.04% yield, surpassing the 10-year Treasury rate of 4.77%, ...
AbbVie Inc. announced a quarterly cash dividend of $1.73 per share, payable on November 16, 2026, to shareholders recorded by October 15, 2026. Since its start in 2013, AbbVie has increased its dividend by over 330%, reflecting strong commitment to r...
